A Phase II of Rituximab in Myasthenia Gravis (NN 103)

Grant

Total Award Amount

  • 16536.00
  • Direct Costs

  • 11249.00
  • Sponsor Award Id

  • Contributor

  • Eroboghene Ubogu   Investigator